Reviewing long-term antidepressants can reduce drug burden: A prospective observational cohort study

British Journal of General Practice

Volumn 62, Issue 604, 2012, Pages

  Johnson, Chris F ^a   Macdonald, Hector J ^b   Atkinson, Pauline ^c   Buchanan, Alasdair I ^d   Downes, Noreen ^e   Dougall, Nadine ^f  

^a NHS GREATER GLASGOW AND CLYDE   (United Kingdom)

^b Inverclyde CHCP   (United Kingdom)

^c Greenock Health Centre   (United Kingdom)

^d IBI Templeton Business Centre   (United Kingdom)

^e Prescribing and Support Unit   (United Kingdom)

^f UNIVERSITY OF STIRLING   (United Kingdom)

Author keywords

Antidepressant; Depression; Drug therapy; Primary care

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; DOSULEPIN; DULOXETINE; ESCITALOPRAM; FLUOXETINE; LOFEPRAMINE; MIRTAZAPINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; VENLAFAXINE;

ADULT; AGED; ANXIETY DISORDER; COHORT ANALYSIS; DEPRESSION; DRUG COST; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; FEMALE; GENERAL PRACTICE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MENTAL HEALTH SERVICE; MIXED ANXIETY AND DEPRESSION; OBSERVATIONAL STUDY; PATIENT REFERRAL; PRESCRIPTION; PROSPECTIVE STUDY; REVIEW; UNITED KINGDOM;

ADULT; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; ANXIETY DISORDERS; DEPRESSIVE DISORDER; FEMALE; GENERAL PRACTICE; HUMANS; LONG-TERM CARE; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PREVALENCE; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES; SCOTLAND; URBAN POPULATION;

EID: 84868152675     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: 10.3399/bjgp12X658304     Document Type: Review

References (41)

1. Middleton N, Gunnell D, Whitley E., et al Secular trends in antidepressant prescribing in the UK, 1975-1998. J Public Health Med 2001; 23(4): 262-267. (Pubitemid 34087287)
2. Mental health policy and practice across Europe: the future direction of mental health care. Maidenhead: McGraw-Hill, Open University Press, 2007.
3. Chen Y, Kelton CM, Jing Y, et al Utilization, price, and spending trends for antidepressants in the US Medicaid Program. Res Social Adm Pharm 2008; 4(3): 244-257.
4. Poluzzi E, Motola D, Silvani C., et al Prescriptions of antidepressants in primary care in Italy: pattern of use after admission of selective serotonin reuptake inhibitors for reimbursement. Eur J Clin Pharmacol 2004; 59(11): 825-831. (Pubitemid 38221661)
5. Information Services Division, Scotland. Antidepressants. Edinburgh: ISD Scotland, 2011. http://www.isdscotlandarchive.scot.nhs.uk/isd/information-and- statistics.jsp?pContentID=3671&p-applic=CCC&p-service=Content.show& (accessed 19 Sep 2012).
6. Munoz-Arroyo R., Sutton M, Morrison J. Exploring potential explanations for the increase in antidepressant prescribing in Scotland using secondary analyses of routine data. Br J Gen Pract 2006; 56(527): 423-428. (Pubitemid 43891224)
7. Moore M, Yuen H, Dunn N., et al Explaining the rise in antidepressant prescribing: A descriptive study using the general practice research database. BMJ 2009; 339(7727): 956-961.
8. Information Services Division, Scotland. General practice depression consultations. Edinburgh: ISD, 2011. http://www.isdscotland.org/isd/3711.html (accessed 19 Sep 2012).
9. National Institute for Health and Clinical Excellence. Depression in adults (update). Clinical Guideline CG90. London: NICE, 2009. http://guidance.nice.org.uk/CG90/(accessed 19 Sep 2012).
10. Anderson IM, Ferrier IN, Baldwin R.C., et al Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines. J Psychopharmacol 2008; 22(4): 343-396. (Pubitemid 351989984)
11. The Scottish Government. Depression Workstream Overview. http://www.scotland.gov.uk/Publications/2010/01/18120533/3 (accessed 8 Oct 2012).
12. Mackie CA, Lawson DH, Campbell A, et al A randomised controlled trial of medication review in patients receiving polypharmacy in a general practice setting. Pharm J 1999; 263: R7.
13. Zermansky AG, Petty DR, Raynor D.K., et al Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. BMJ 2001; 323(7325): 1340-1343. (Pubitemid 33152213)
14. Johnson C, Thomson A. Prescribing support pharmacists support appropriate benzodiazepine and Z-drug reduction 2008/09 - experiences from North Glasgow. Clin Pharm 2010; 3(SUPPL. 1): S5-S6.
15. Donoghue J, Tylee A, Wildgust H. Cross sectional database analysis of antidepressant prescribing in general practice in the United Kingdom, 1993-5. BMJ 1996; 313(7061): 861-862. (Pubitemid 26335213)
16. McManus P, Mant A, Mitchell P., et al Use of antidepressants by general practitioners and psychiatrists in Australia. Aust N Z J Psychiatry 2003; 37(2): 184-189. (Pubitemid 36592728)
17. Truter I, Kotze TJ An investigation into the prescribing patterns of selective serotonin re-uptake inhibitors in South Africa. J Clin Pharm Ther 1996; 21(4): 237-242. (Pubitemid 26354381)
18. Scottish Government. Scottish index of multiple deprivation: 2009 general report. Edinburgh: Scottish Government, August 2010. http://www.scotland.gov. uk/Publications/2009/10/28104046/0 (accessed 19 Sep 2012).
19. Scottish Government, Inequalities in health. Report of the Measuring Inequalities in Health Working Group. Edinburgh: Scottish Government, November 2003. http://www.scotland.gov.uk/Resource/Doc/47171/0013513.pdf (accessed 19 Sep 2012).
20. Prescribing and Information System for Scotland (PRISMS) http://www.isdscotland.org/Health-Topics/Prescribing-and-Medicines/PRISMS/ (accessed 8 Oct 2012).
21. World Health Organization. Definitions and general considerations. Geneva: WHO, 2009. http://www.whocc.no/ddd/definition-and-general-considera/ (accessed 19 Sep 2012)
22. General Register Office Scotland. http:www.gro-scotland.gov.uk (accessed 19 Sep 2012).
23. British National Formulary 58. London: BMA and Royal Pharmaceutical Society, 2009.
24. Adli M, Baethge C, Heinz A., et al Is dose escalation of antidepressants a rational strategy after a medium-dose treatment has failed? A systematic review. Eur Arch Psychiatry Clin Neurosci 2005; 255(6): 387-400. (Pubitemid 43029828)
25. Corruble E, Guelfi JD Does increasing dose improve efficacy in patients with poor antidepressant response: a review. Acta Psychiatr Scand 2000; 101(5): 343-348. (Pubitemid 30232998)
26. Morrison J, Anderson MJ, Sutton M, et al Factors influencing variation in prescribing of antidepressants by general practices in Scotland. Br J Gen Pract 2009; 59(559): e25-31.
27. Donoghue JM, Tylee A. The treatment of depression: prescribing patterns of antidepressants in primary care in the UK. Br J Psych 1996; 168(2): 164-168.
28. Williams N, Simpson AN, Simpson K, Nahas Z. Relapse rates with long-term antidepressant drug therapy: a meta-analysis. Hum Psychopharmacol Clin Exp 2009; 24(5): 401-408.
29. Hull SA, Aquino P, Cotter S. Explaining variation in antidepressant prescribing rates in east London: a cross sectional study. Fam Pract 2005 2005; 22(1): 37-42. (Pubitemid 40309603)
30. Petty DR, House A, Knapp P., et al Prevalence, duration and indications for prescribing of antidepressants in primary care. Age Ageing 2006; 35(5): 523-526. (Pubitemid 44295644)
31. Schofield P, Crosland A, Waheed W., et al Patients' views of antidepressants: from first experiences to becoming expert. Br J Gen Pract 2011; 61(585): 142-148.
32. Cornford CS, Hill A, Reilly J. How patients with depressive symptoms view their condition: a qualitative study. Fam Pract 2007; 24(4): 358-364. (Pubitemid 47399893)
33. Middleton DJ, Cameron IM, Reid IC Continuity and monitoring of antidepressant therapy in a primary care setting. Qual Prim Care 2011; 19(2): 109-113.
34. Geddes JR, Carney SM, Davies C, et al Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 2003; 361(9358): 653-661. (Pubitemid 36246547)
35. Coupland C, Dhiman P, Morriss R., et al Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ 2011; 343: d4551.
36. Zermansky AG. Who controls repeats? Br J Gen Pract 1996; 46(412): 643-647. (Pubitemid 26388407)
37. Saastamoinen LK, Enlund H, Klaukka TJ Repeat prescribing process in primary care: a qualitative study. Int J Pharm Pract 2008; 16(3): 155-157. (Pubitemid 351702392)
38. Quality and Outcomes Framework guidance for GMS contract 2011/12. Delivering investment in general practice. London: BMA NHS Employers, April 2011. http://www.nhsemployers.org/SiteCollectionDocuments/ QOFguidanceGMScontract-2011-12-FL%2013042011.pdf (accessed 19 Sep 2012).
39. Andrews G. Should depression be managed as a chronic disease? BMJ 2001; 322(7283): 419-421. (Pubitemid 32193280)
40. Rix S, Paykel ES, Lelliott P, et al Impact of a national campaign on GP education: an evaluation of the Defeat Depression Campaign. Br J Gen Pract 1999; 49(439): 99-102. (Pubitemid 29068972)
41. Paykel ES, Freeling P. Treatment of depression in primary care. BMJ 1992; 304(6838): 1380-1381.